Search
for

    Sort by

    Community Join

    270-300 / 1000+ results

      community Anagen is now selling pyrilutamide

      in Product  137 upvotes 2 years ago
      Pyrilutamide, a potential hair loss treatment that has recently been released for sale, and is thought to have similar efficacy to Dutasteride without side effects. It was discussed in terms of its effectiveness compared to Finasteride, its use by females, and whether it can be safely mixed with RU58841.

      community So is GT20029 available on the grey market anywhere?

      in Treatment  15 upvotes 5 months ago
      The conversation discusses the availability of GT20029, a new topical hair loss treatment with fewer side effects than Minoxidil or finasteride. Users suggest using finasteride to preserve hair until GT20029 becomes available.

      community Further prolactin research....

      in Research/Science  6 upvotes 8 months ago
      HMI 115 did not work as expected for hair regrowth in humans, unlike in macaque monkeys. There is anticipation for further research on prolactin's role in hair loss, with expectations that pharmaceutical companies will likely solve this before universities.

      community Pyrilutamide kintor pharmaceutical

      in Chat  6 upvotes 11 months ago
      The conversation is about seeking information on GT20029 from Kintor Pharmaceutical as a potential hair loss cure and inquiring about experiences with CosmeaRNA.

      community Dutasteride + Oral Minoxidil , 5 Months

      in Update  7 upvotes 4 months ago
      The post discusses using oral Minoxidil and Dutasteride for hair loss. Minoxidil improved hair growth with mild hypertrichosis, while Dutasteride caused severe acne, cognitive issues, and mild anxiety, leading the user to prefer Finasteride.

      community Still hope on Kintor due to the new announcement

      in Treatment  18 upvotes 9 months ago
      The conversation is about Kintor's announcement indicating continued hope for their product KX-826 as a treatment for Alopecia Androgenetica. Specific treatments mentioned are Minoxidil, Finasteride, and RU58841.

      community This sub is very toxic towards people who don’t blindly follow the fin mafia

      in Treatment  226 upvotes 1 year ago
      The conversation criticizes the negative attitude towards those concerned about side effects from hair loss treatments like finasteride and minoxidil, or who prefer natural remedies. Specific treatments discussed include finasteride, minoxidil, rosemary oil, and RU58841, with an agreement that finasteride and minoxidil are proven effective.

      community Chances GT20029 releases by 2028?

      in Technology  7 upvotes 1 year ago
      The conversation is about hair loss treatments, specifically the anticipation for the release of a new treatment, GT20029, by 2028. Users are discussing their experiences with current treatments like finasteride and dutasteride, and the potential of future treatments, including FAK inhibitors and verteporfin trials.

      community Ru58841 after a hair transplant

      in Transplants  7 upvotes 2 months ago
      A user discussed their hair transplant progress and mentioned using 1mg Finasteride, 5% Topical Minoxidil, and recently starting 5% RU58841. They are seeking advice on whether to use RU58841 at month 4 post-transplant.

      community What are the 'safer' alternatives to RU58841?

      in Research/Science  2 upvotes 2 months ago
      A user discusses switching from RU58841 to Pyrilutamide due to side effects like fatigue, brain fog, and elevated heart rate. They have used dutasteride, finasteride, and minoxidil, and are seeking safer alternatives.

      community Anyone lossing Hair wen apply RU/Minox?

      in Minoxidil  3 upvotes 3 months ago
      The user reports losing a significant amount of hair when applying RU58841 and Minoxidil but loses much less hair when massaging or brushing without these treatments. They are concerned about the increased hair loss associated with these products.

      community We don’t actually know what’s going on.

      in Treatment  212 upvotes 5 months ago
      Hair loss treatments vary greatly in effectiveness and timelines, with no guaranteed results. Common treatments mentioned include finasteride, minoxidil, and RU58841.

      community M22 Shedding recovery fin 1mg min 1ml

      in Finasteride/Dutasteride  142 upvotes 7 months ago
      A user shared their experience with hair loss treatment using finasteride (1mg) and minoxidil (1ml), noting significant shedding phases but hoping for improvement. Shedding is a common synchronized effect of the treatment, which may desynchronize over time, potentially taking over 5 years.

      community Any news on scube3? It's my only hope at this point guys. Where are things with it? How far away is it? Could be available in 2024?

      in Technology  8 upvotes 9 months ago
      The conversation is about a person rapidly losing hair and seeking information on the availability of a new treatment called scube3, as they have experienced side effects from current treatments like Minoxidil and finasteride. They are hoping scube3 will be approved soon as they believe it's their only remaining option.

      community New treatment? Minox + Bimatoprost

      in Treatment  6 upvotes 10 months ago
      A user discussed a new hair loss treatment combining 5% Minoxidil with Bimatoprost 0.3mg/ml, applied once daily. They referenced a study suggesting Bimatoprost may be more effective than Minoxidil.

      community Anti androgen shed all over scalp

      in Treatment  3 upvotes 11 months ago
      The user is experiencing intense hair shedding all over the scalp after applying pyrilutamide to the hairline and taking oral castor oil. They are also using topical finasteride and latanoprost, but are unsure which treatment is causing the shedding.

      community There is news from pyrilutamide?

      in Product  32 upvotes 1 year ago
      The discussion is about a hair loss drug called pyrilutamide. Users discuss its efficacy, safety, and expected market release around 2025-2026, with some expressing concerns about the authenticity of current market offerings.